SDSangeeta Dey

Sangeeta Dey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sangeeta Dey has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Compulsory treatment order and rehospitalisation: A New Zealand study

    by Sangeeta Dey, Graham Mellsop, Zuzana Obertova, Matthew Jenkins

    Objective: The effectiveness of compulsory treatment orders (CTO) in psychiatric practice is an area in need of evidence. There are no recent New Zealand publications on outcomes for patients under CTOs. This study examined the association between CTOs and subsequent rehospitalisation for patients with schizophrenia or related disorders. Method: Two year outcome data for 326 consecutive patients discharged in 2013 and 2014 was obtained from the Programme for the Integration of Mental Health Data database. Regression analyses were performed with rehospitalisation as the main outcome. Results: For the 54% of patients discharged under CTOs, rehospitalisation was 2–4 times more likely for the CTO group than for voluntary patients. Patients under CTOs also spent longer in hospital post index admission (IA). However, patients placed under CTOs during IA stayed longer than those under CTOs prior to IA. Ethnicity did not contribute significantly to any of the findings. Conclusion: This study did not show that patients under CTOs were associated with subsequent reduced resource use. The subgroup analysis suggested that studies with a longer follow-up period may provide better insight into the utility of CTOs.


  • Open Access

    Bacteriological Profile of Organisms Isolated from Patients with Conjunctivitis in Katihar, Bihar

    by Priya Sinha, Sangeeta Dey, Aninda Sen, Kahkashan Akhter, Alok Kumar, Shreshy Singh

    BACKGROUND Conjunctivitis is one of the most common nontraumatic eye complaints and is one of the most frequently reported diseases in the outpatient and emergency departments. Bacterial conjunctivitis has been reported as one of the most common type of infectious conjunctivitis after viral infections. It is also considered as the primary cause of acute conjunctivitis in children. This study was conducted to isolate and identify organisms causing bacterial conjunctivitis and to determine their in vitro susceptibility or resistance. METHODS This descriptive study was conducted in the Departments of Ophthalmology and Microbiology at Katihar Medical College from December 2018 to May 2020. Sociodemographic and clinical data were collected from 175 patients using structured questionnaire. External ocular specimens were collected using sterile swabs and inoculated on blood agar, MacConkey’s agar and chocolate agar. Presumptive isolates were further identified by a series of biochemical tests. All isolated organisms were tested for their in vitro antimicrobial susceptibility against various antibiotics using the Kirby-Baur disk diffusion method. RESULTS A total of 175 samples were collected, out of which, 62.8 % (110 / 175) showed growth of bacteria. Maximum cases of bacterial conjunctivitis were seen in the age group 11 - 20 years. The male to female ratio was 2.7:1. Maximum frequency of bacterial conjunctivitis was observed from May to September. Staphylococcus aureus was the most common bacteria isolate 65.5 % (72 / 110) followed by Staphylococcus epidermidis 19.1 % (21 / 110). Most of the Staphylococcus aureus isolates were found to be sensitive to moxifloxacin 98.6 % (71 / 72) and gentamicin 95.8 % (69 / 72). 25 % (18 / 72) of Staphylococcus aureus strains were found to be resistant to cefoxitin and were considered as methicillin-resistant Staphylococcus aureus (MRSA) strains. Maximum numbers of gram-negative strains were sensitive to moxifloxacin 100.0 % (9 / 9) followed by tobramycin 88.9 % (8 / 9). Pseudomonas aeruginosa strains showed maximum sensitivity to moxifloxacin 100.0 (8 / 8) followed by ofloxacin and ciprofloxacin 62.5 % (5 / 8). CONCLUSIONS This study provides an insight into the organisms isolated from cases of bacterial conjunctivitis in Katihar District of Bihar. Determining the susceptibility pattern of these pathogens to available antibiotics is crucial for effective management of bacterial conjunctivitis especially when treatment has to be given empirically. KEY WORDS Bacterial Conjunctivitis, Antibiogram


  • Sociodemographic and clinical variables associated with discharge under compulsory treatment orders

    by Sangeeta Dey, Graham Mellsop, Zuzana Obertova, Matthew Jenkins

    Objective: To document the sociodemographic and clinical variables associated with discharge under compulsory treatment orders in patients with schizophrenia or related disorders. Method: Information on various sociodemographic and clinical variables were extracted from the clinical files of 349 patients discharged from an adult (age 18–65) inpatient psychiatric unit with diagnoses of schizophrenia or related disorders. Univariate and multiple logistic regression analyses with legal compulsion (compulsory versus voluntary) as outcomes were applied. Results: Two hundred of the 349 discharged patients were placed under compulsory treatment orders. In the univariate logistic regression analysis, unemployment, diagnosis of schizophrenia, forensic history, dosage of antipsychotics, prescription and frequency of injectable antipsychotics, polypharmacy and a hospital stay of more than 28 days were associated with compulsory status. Being married or in partnership and living with partner was associated with voluntary status. Multiple regression models respectively confirmed most of these relationships observed in the univariate analyses. Conclusion: Clarification of the apparent drivers for compulsory treatment may help thoughtful reductions in the use of compulsion.


  • Sodium valproate prescription to women of childbearing age in a New Zealand inpatient psychiatric unit

    by Rachel Goldspink, Toni Pumipi, Sangeeta Dey, David B Menkes

    Objective: Sodium valproate’s teratogenicity has prompted increasing restriction in its use. It is still widely prescribed to women of childbearing age in New Zealand. To examine this problem, we audited the prescribing pattern of sodium valproate in a psychiatric inpatient unit in New Zealand. Method: We reviewed the clinical records of women admitted over a 2-year period (2016–2018). Results were analysed and compared with local and international guidelines. Results: Five hundred and thirty-four women of child-bearing age were admitted over the sampling period, 96 of whom (18%) were prescribed valproate on discharge. Half of these patients had diagnoses other than bipolar affective disorder, valproate’s only approved psychiatric indication in New Zealand. Pregnancy testing and contraception status were documented in a minority (29 and 10 cases, respectively). Teratogenic risk discussion was documented in only 11 cases. Conclusions: Prescription of valproate to women of childbearing age in our sample currently falls well short of best practice. Urgent action at both clinician and organisational levels is required to address this risk.


  • Open Access

    Comparing legislation for involuntary admission and treatment of mental illness in four South Asian countries

    by Sangeeta Dey, Graham Mellsop, Kate Diesfeld, Vajira Dharmawardene, Susitha Mendis, Sreemanti Chaudhuri, Aniruddha Deb, Nafisa Huq, Helal Uddin Ahmed, Mohammad Shuaib, et al.

    Background: Involuntary admission or treatment for the management of mental illness is a relatively common practice worldwide. Enabling legislation exists in most developed and high-income countries. A few of these countries have attempted to align their legislation with the United Nations Convention on the Rights of Persons with Disabilities. This review examined legislation and associated issues from four diverse South Asian countries (Bangladesh, India, Pakistan and Sri Lanka) that all have a British colonial past and initially adopted the Lunacy Act of 1845. Method: A questionnaire based on two previous studies and the World Health Organization checklist for mental health legislation was developed requesting information on the criteria and process for involuntary detention of patients with mental illness for assessment and treatment. The questionnaire was completed by psychiatrists (key informants) from each of the four countries. The questionnaire also sought participants’ comments or concerns regarding the legislation or related issues. Results: The results showed that relevant legislation has evolved differently in each of the four countries. Each country has faced challenges when reforming or implementing their mental health laws. Barriers included legal safeguards, human rights protections, funding, resources, absence of a robust wider health system, political support and sub-optimal mental health literacy. Conclusion: Clinicians in these countries face dilemmas that are less frequently encountered by their counterparts in relatively more advantaged countries. These dilemmas require attention when implementing and reforming mental health legislation in South Asia.


  • Abstract 3510: Small molecule ACSS2 inhibitors target acetate metabolizing tumor cells in hypoxic conditions

    by Monali Banerjee, Sourav Basu, Debjani Chakraborty, Ritesh Shrivastava, Sandip Middya, Rajib Ghosh, Dharmendra Yadav, Arghyotri Sinha, Avratanu Das, Navin Pandit, et al.

    BACKGROUND Tumors such as glioblastoma proliferating under hypoxic, hypoglycemic and hypolipidemic conditions derive almost half of their nutritional requirement from the short chain fatty acid acetate. Acetyl CoA synthetases (ACSS 1 to 3) are a family of enzymes that metabolize acetate to the multifunctional metabolite acetyl-CoA. Acetyl-coA is a key precursor of cellular biomass and is required for epigenetic modification. There is an increasing body of clinical evidence that places acetate and ACSS2 at a critical metabolic node in tumors. We have developed potent small molecule enzyme inhibitors of ACSS2 that block the functional activity of the enzyme in vitro and in vivo. Furthermore, these inhibitors synergize with known chemotherapeutics to eliminate cancer cells in hypoxic conditions. METHODS A pharmacophore based medicinal chemistry campaign yielded initial hits which were refined in subsequent rounds of structure activity relationships. ACSS2 activity was measured in cell free and cellular assays by monitoring the conversion of radiolabelled acetate to biomass in depleted oxygen environments and in combination with chemotherapeutics such as doxorubicin. RESULTS Our medicinal chemistry campaign yielded several highly potent ACSS2 specific enzyme inhibitors with good pharmacokinetic properties in the rodent. Our lead compound CRD1400 is an ACSS2 specific inhibitor with low nanomolar potency and kills acetate dependent tumor cells and sensitizes several tumor cell lines to the chemotherapeutic doxorubicin. CRD1400 is has been selected for further assessment in patient derived xenograft models based on its potency for increased cell killing under hypoxic conditions. CONCLUSIONS Inhibition of the enzyme ACSS2 depletes tumor cells of the nutrient acetate and provides a new modality of attacking metabolic vulnerabilities in tumors. When used in combination, CRD1400 reduces chemotherapeutic resistance that arises in low oxygen environments common in tumors and enhances the potency of commonly used cancer medication. Citation Format: Monali Banerjee, Sourav Basu, Debjani Chakraborty, Ritesh Shrivastava, Sandip Middya, Rajib Ghosh, Dharmendra Yadav, Arghyotri Sinha, Avratanu Das, Navin Pandit, Mohinder Naiya, Sabyasachi Debnath, Sangeeta Dey, Debottam Dasgupta, Nirmal Das, Anuj Singh, Dipayan Sarkar, Sukanya Sarkar, Ganesh Narasipuram, Nagaswami Mane, Nicky Singhal, Nidhi Rawat, Anindita Middya, Arjun Surya. Small molecule ACSS2 inhibitors target acetate metabolizing tumor cells in hypoxic conditions [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 3510.